A Córdoba-based HealthTech startup, SaludInnova, launched its first international export to Peru on June 1, 2026, distributing telemedicine software to six clinics in Lima, according to a regulatory filing. The move represents the company’s initial step beyond Argentina’s domestic market.
SaludInnova’s Export Strategy
SaludInnova, a health technology firm incorporated in 2019, finalized a licensing agreement with Peruvian healthcare provider Clínica del Río in late May 2026, enabling the deployment of its AI-driven diagnostics platform in Lima. The software, designed to streamline chronic disease management, was first tested in Córdoba in 2023. A regulatory filing with Argentina’s National Directorate of Industrial Property (DNP) confirms the export of 120 software licenses to Peru, with an additional 30 licenses pending approval.
The company’s CEO, Martín Vidal, stated in a June 1 press release:
We are proud to extend our solutions to Peru, a market with growing demand for digital health tools. This partnership underscores our commitment to regional integration and technological innovation.
Martín Vidal, CEO, SaludInnova
The statement was distributed via the firm’s official website and echoed in a local business publication, *La Nueva Industria*. No further details on revenue projections or partnership terms were disclosed in the filing.
Regulatory and Market Context
Peru’s Ministry of Health (Minsa) has prioritized telemedicine expansion since 2024, allocating $120 million to support private-sector digital health initiatives. SaludInnova’s entry aligns with this policy, though the firm is not explicitly listed in Minsa’s 2026 approved vendor registry. A spokesperson for the ministry declined to comment on the company’s specific role, citing ongoing evaluations of foreign software providers.
Argentina’s export data for May 2026, published by the National Institute of Statistics and Census (INDEC), shows a 14% year-over-year increase in tech-sector exports. SaludInnova’s transaction—valued at $850,000—represents a small fraction of this growth but marks a significant milestone for the firm. The company’s 2025 financial report, filed with the Argentine Securities Commission (BCRA), listed $2.1 million in domestic revenue, with no prior international activity recorded.
Challenges and Industry Dynamics
HealthTech exports to Peru face regulatory hurdles, including compliance with the country’s Data Protection Law (Ley de Protección de Datos Personales, 2022). SaludInnova’s software must undergo certification by Peru’s National Superintendence of Personal Data (SUNARP) before full deployment. A SUNARP spokesperson confirmed that the application is under review but provided no timeline.
Industry analysts note that Argentina’s HealthTech sector remains nascent compared to regional leaders like Chile and Brazil. “While SaludInnova’s move is promising, it highlights the challenges of scaling beyond local markets,” said Laura Montes, a digital health consultant based in Buenos Aires. “Peru’s regulatory environment is more mature, but competition from established players like Brazil’s Nubank Health is intense.”
The company’s expansion also reflects broader trends in Latin American tech. A 2026 report by the Inter-American Development Bank (IDB) found that 37% of health startups in the region plan to enter at least one foreign market by 2027, up from 22% in 2023. However, only 12% of these firms have secured international partnerships, indicating high barriers to entry.
Implications for Argentina’s Tech Sector
SaludInnova’s export activity could signal a shift in Argentina’s tech ecosystem, which has historically focused on domestic consumption. The firm’s success may encourage other startups to pursue international ventures, particularly in markets with aligned regulatory frameworks. However, experts caution that scaling requires significant investment in compliance, localization, and partnerships.
“This is a small but symbolic step,” said Diego Morales, a venture capitalist specializing in Latin American tech. “For Argentina’s HealthTech sector to compete globally, firms need to navigate complex regulatory landscapes and build trust with foreign stakeholders. SaludInnova’s experience will be critical for others considering similar moves.